Inhomogeneous dose escalation for NSCLC: Full dosimetric analysis of the phase III NARLAL2 trial

被引：0
|
作者：
Lutz, Christina M. [1 ]
Nielsen, Tine B. [2 ]
Lund, Mikkel D. [3 ]
Schytte, Tine [2 ]
Hansen, Torben S. [3 ]
Hoffmann, Lone [1 ,4 ]
Ottosson, Katarina W. [5 ]
Peucelle, Cecile [6 ]
Rusten, Espen [7 ]
Levin, Nina [8 ]
Brink, Carsten [2 ]
Gronberg, Bjorn H. [8 ,9 ]
Haakensen, Vilde D. [7 ]
Hansen, Olfred [2 ]
Khalil, Azza A. [1 ,4 ]
Knap, Marianne M. [1 ]
Kristiansen, Charlotte [3 ]
Nielsen, Morten [2 ]
Persson, Gitte F. [5 ,10 ]
Pohl, Mette [6 ]
Thing, Rune S. [3 ]
Moller, Ditte S. [1 ,4 ]
机构：
[1] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[2] Odense Univ Hosp, Dept Oncol, Odense, Denmark
[3] Univ Hosp Southern Denmark, Vejle Hosp, Dept Oncol, Vejle, Denmark
[4] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[5] Copenhagen Univ Hosp Herlev & Gentofte, Dept Oncol, Herlev, Denmark
[6] Rigshosp, Dept Oncol, Copenhagen, Denmark
[7] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[8] St Olavs Hosp, Dept Oncol, Trondheim, Norway
[9] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway
[10] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
NSCLC; dose escalation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2381
引用
收藏
页码：S1736 / S1739
页数：5
相关论文
共 50 条
  • [41] Cardiac Toxicity after Radiation for Stage III NSCLC: Pooled Analysis of Dose-Escalation Trials Delivering 70-90 Gy
    Wang, Kyle
    Eblan, Michael
    Lipner, Matthew
    Deal, Allison
    Zagar, Timothy
    Lee, Carrie
    Jensen, Brian
    Mavroidis, Panayiotis
    Rosenman, Julian
    Stinchcombe, Thomas
    Marks, Lawrence
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S339 - S340
  • [42] STEPWISE DOSE ESCALATION METHOD FOR NILOTINIB STOP TRIAL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (STEP STOP TRIAL): A MULTICENTER PHASE 2 TRIAL
    Ota, K.
    Akagi, T.
    Yamagata, K.
    Mayama, K.
    Fujii, T.
    Kamata, K.
    Fukuda, S.
    Kubo, K.
    HAEMATOLOGICA, 2016, 101 : 738 - 738
  • [43] Radiotherapy Dose Escalation in Unresectable Ewing's Sarcoma/PNET: Final Results of a Single Institute Phase III Randomized Controlled Trial
    Laskar, S.
    Sinha, S.
    Chatterjee, A.
    Khanna, N.
    Puri, A.
    Gulia, A.
    Nayak, P.
    Vora, T.
    Chinnaswamy, G.
    Prasad, M.
    Juvekar, S.
    Desai, S.
    Janu, A.
    Rangarajan, V.
    Purandare, N.
    Shah, S.
    Rekhi, B.
    Jambhekar, N.
    Muckaden, M. A.
    Kurkure, P.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S16 - S16
  • [44] A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1049 - S1050
  • [45] Dose Escalation to Target Volumes of Helical Tomotherapy for Pancreatic Cancer in the Phase 1-2 Clinical Trial
    Xia, T.
    Chang, D.
    Wang, Y.
    Li, J.
    Wu, W.
    Zhu, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S303 - S303
  • [46] PS 2 Patients with Advanced EGFR Mutant NSCLC: Subset Analysis of a Phase III Randomized Trial Comparing Gefitinib to Gefitinib with Chemotherapy
    Prabhash, K.
    Noronha, V.
    Patil, V.
    Joshi, A.
    Chougule, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S395 - S395
  • [47] Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)
    Laprie, Anne
    Noel, Georges
    Chaltiel, Leonor
    Truc, Gilles
    Sunyach, Marie-Pierre
    Charissoux, Marie
    Magne, Nicolas
    Auberdiac, Pierre
    Biau, Julian
    Ken, Soleakhena
    Tensaouti, Fatima
    Khalifa, Jonathan
    Sidibe, Ingrid
    Roux, Franck-Emmanuel
    Vieillevigne, Laure
    Catalaa, Isabelle
    Boetto, Sergio
    Uro-Coste, Emmanuelle
    Supiot, Stephane
    Bernier, Valerie
    Filleron, Thomas
    Mounier, Muriel
    Poublanc, Muriel
    Olivier, Pascale
    Delord, Jean-Pierre
    Cohen-Jonathan-Moyal, Elizabeth
    NEURO-ONCOLOGY, 2024, 26 (01) : 153 - 163
  • [48] Phase I Dose-Escalation Trial of Proton Beam Therapy with Concurrent Full-Dose Chemotherapy for Patients with C stage IB/II/III (non-T4) Esophageal Squamous Cell Carcinoma
    Akimoto, T.
    Kojima, T.
    Hojo, H.
    Onozawa, M.
    Okumura, M.
    Nakamura, M.
    Motegi, A.
    Hotta, K.
    Baba, H.
    Zenda, S.
    Fujita, T.
    Nakamura, N.
    Daiko, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S130 - S130
  • [49] Oral vinorelbine concomitantly with thoracic radiotherapy (RT) in locally-advanced or inoperable stage III non-small cell lung cancer (NSCLC): interim results of a phase I dose escalation trial
    Krzakowski, M.
    Gridelli, C.
    Paccagnella, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 382 - 383
  • [50] RESULTS OF A PHASE II TRIAL ON INDIVIDUALIZED RADIATION DOSE-ESCALATION BASED ON NORMAL TISSUE CONSTRAINTS IN CONCURRENT CHEMO-RADIATION FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
    Van Baardwijk, Angela
    Reymen, Bart
    Wanders, Rinus
    Borger, Jacques
    Dingemans, Anne-Marie C.
    Bootsma, Gerben
    Pitz, Cordula
    Lunde, Ragnar
    Geraedts, Wiel
    Peters, Frank
    Lambin, Philippe
    De Ruysscher, Dirk
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S378 - S379
12345